Abstract

The therapeutic targets of SCS have broadly expanded, yet its influence on central and peripheral neuronal pathways, as well as the autonomic nervous system remains poorly understood. Few case reports have demonstrated significant changes in gastrointestinal function and symptomatology with neurostimulation targeted to the thoracic dorsal column. In reports by La Grua and Thakkar, et al, patients developed either new onset diarrhea or abdominal distension and constipation following SCS activation.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call